Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
1,375.30
-4.70 (-0.34%)
Nov 16, 2026, 3:00 PM IST
Dr. Reddy's Laboratories Market Cap
Dr. Reddy's Laboratories has a market cap or net worth of 1.14 trillion as of November 13, 2026. Its market cap has increased by 10.30% in one year.
Market Cap
1.14T
Enterprise Value
1.14T
Revenue
329.84B
Global Rank
n/a
Country Rank
n/a
PE Ratio
40.96
ChartMarket Cap Chart
Since May 31, 1999, Dr. Reddy's Laboratories's market cap has increased from 21.00B to 1.14T, an increase of 5,342.84%. That is a compound annual growth rate of 15.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 1.14T | 8.04% |
| Dec 31, 2025 | 1.06T | -8.50% |
| Dec 31, 2024 | 1.16T | 19.80% |
| Dec 29, 2023 | 965.41B | 37.28% |
| Dec 30, 2022 | 703.23B | -13.66% |
| Dec 31, 2021 | 814.50B | -5.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 3.04T |
| Laurus Labs | 1.31T |
| Zydus Lifesciences | 1.19T |
| Cipla | 1.12T |
| Mankind Pharma | 1.09T |
| Aurobindo Pharma | 1.05T |
| Glenmark Pharmaceuticals | 745.06B |
| Alkem Laboratories | 611.46B |